BELGRADE, Mont.--(BUSINESS WIRE)--Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for Q1 2019, and preliminary revenues for Q2 2019. Sales and Product Offerings Completion of the relocated processing facility to Belgrade, Montana and expanding reach into dental markets. Gross profit margin was 69% for the three months ended… The post Lattice Biologics Ltd. Reports First Quarter 2019 Results appeared first on Public Wire.
https://www.publicwire.com/lattice-biologics-ltd-reports-first-quarter-2019-results/
No comments:
Post a Comment